 Anchiano Therapeutics Ltd. ANCN the Company today announced it has elected to hold its 2020 Annual General Meeting of Shareholders the Annual Meeting as a virtual meeting due to the ongoing public health concerns related to the coronavirus COVID-19 pandemic. As described in the proxy materials for the Annual Meeting the Proxy Materials, shareholders as of the close of business on March 23, 2020, the record date, are entitled to participate in the Annual Meeting. Shareholders can participate in the Annual Meeting via the internet by visiting and entering the meeting number 280 326 067. 